Behavior Matters: Redesigning The Clinical Trial To Account For Behavior
Friday, June 19, 2015 - 06:10
in Health & Medicine
When a new type of drug or therapy is discovered, double-blind randomized controlled trials (DBRCTs) are the gold standard for evaluating them. These trials, which have been used for years, were designed to determine the true efficacy of a treatment free from patient or doctor bias, but they do not factor in the effects that patient behaviors, such as diet and lifestyle choices, can have on the tested treatment. read more